Hematology Practice Questions

Q: Which of the following is NOT true regarding Waldenström's macroglobulinemia?

Hypercalcemia is present.. Waldenström’s Macroglobulinemia (WM) is a **lymphoplasmacytic lymphoma** characterized by the infiltration of the bone marrow by neoplastic cells that secrete a monoclonal **IgM** protein [1]. **Why Option D is the Correct Answer:** Unlike Multiple Myeloma (MM), Waldenström’s Macroglobulinemia is typically **not** associated with lytic bone lesions or significant bone destruction [1]. Consequently, **hypercalcemia and renal failure (due to light chains) are rare** in WM. If a patient presents with high IgM and lytic lesions, the diagnosis is more likely "IgM Myeloma" rather than WM. **Analysis of Incorrect Options:** * **Option A (Lymphadenopathy):** WM is a lymphoma. Unlike Multiple Myeloma, patients frequently present with organomegaly, including **lymphadenopathy and hepatosplenomegaly** (in ~20-40% of cases) [1]. * **Option B (Blood Viscosity):** IgM is a large pentameric molecule. High levels significantly increase serum viscosity, leading to **Hyperviscosity Syndrome** (headache, visual disturbances, and mucosal bleeding) [1]. * **Option C (IgM Increase):** By definition, WM involves a monoclonal gammopathy of the **IgM** class (usually >3 g/dL) [1]. **NEET-PG High-Yield Pearls:** 1. **Genetic Marker:** Over 90% of WM patients possess the **MYD88 L265P mutation**. 2. **Clinical Triad:** Hyperviscosity, lymphadenopathy/splenomegaly, and anemia [1]. 3. **Diagnosis:** Bone marrow biopsy shows **lymphoplasmacytic infiltration** (CD19+, CD20+, CD22+, CD10-, CD5-). 4. **Dutcher Bodies:** Periodic acid–Schiff (PAS)-positive intranuclear inclusions of immunoglobulins are a classic pathological finding. 5. **Treatment:** Plasmapheresis is the immediate treatment for symptomatic hyperviscosity; Rituximab-based regimens are used for definitive therapy [1].

Q: A 23-year-old female presents with a 2-year history of anemia and jaundice. A peripheral smear shows spherocytes. What is the most appropriate investigation to perform?

Coombs test. **Explanation:** The clinical presentation of anemia, jaundice, and spherocytes on a peripheral smear suggests **Spherocytosis**. In clinical practice, the two primary differentials for spherocytes are **Hereditary Spherocytosis (HS)** and **Autoimmune Hemolytic Anemia (AIHA)**. **Why Coombs Test is the correct answer:** The first and most critical step in the diagnostic algorithm for spherocytosis is to differentiate between an inherited membrane defect (HS) and an acquired immune-mediated process (AIHA) [1]. The **Direct Antiglobulin Test (Coombs test)** is the gold standard for this [1]. A positive Coombs test confirms AIHA, while a negative test points toward HS. Since AIHA is a common cause of acquired spherocytosis and requires entirely different management (steroids vs. splenectomy), it must be ruled out first. **Analysis of Incorrect Options:** * **A. Reticulocyte count:** While this will be elevated in any hemolytic anemia, it is non-specific and does not help differentiate the cause of spherocytes. * **B. Osmotic fragility test:** Historically used for HS, this test is now largely replaced by the **EMA Binding test** (Eosin-5-maleimide flow cytometry). Furthermore, osmotic fragility is increased in *both* HS and AIHA, making it less useful than the Coombs test for initial differentiation. * **D. Bone marrow aspiration:** This is generally not indicated in the workup of hemolytic anemias unless a primary bone marrow failure or malignancy is suspected. **NEET-PG High-Yield Pearls:** * **Spherocytes** are smaller, denser RBCs that have lost their central pallor due to loss of surface area [1]. * **Confirmatory test for HS:** EMA Binding test (Most sensitive/specific). * **MCHC:** Characteristically **elevated** (>36 g/dL) in Hereditary Spherocytosis [1]. * **Treatment of choice for HS:** Splenectomy (usually delayed until after age 5-6 to reduce sepsis risk).

Q: During the evaluation of a case of polycythemia, which of the following investigations is LEAST likely to be required to establish the cause?

Serum iron profile. The evaluation of polycythemia focuses on distinguishing between **Primary Polycythemia** (Polycythemia Vera - PV) and **Secondary Polycythemia** (driven by Erythropoietin) [1]. ### Why Serum Iron Profile is the Least Likely Required While iron deficiency can occasionally occur in Polycythemia Vera due to increased red cell production, a **Serum Iron Profile** is not a diagnostic tool to establish the *cause* of polycythemia. In fact, iron deficiency can lead to microcytosis, which might paradoxically mask the rise in hematocrit, but it does not help differentiate between primary and secondary causes. ### Explanation of Other Options * **Erythropoietin (EPO) Level:** This is the initial step in the algorithm. Low EPO levels suggest Polycythemia Vera (Primary), while high levels suggest Secondary Polycythemia (e.g., chronic hypoxia or EPO-secreting tumors). * **Arterial Blood Gas (ABG):** This is crucial to identify **hypoxia-driven secondary polycythemia**. An $SaO_2 < 92\%$ indicates that the polycythemia is a compensatory response to chronic lung disease, cyanotic heart disease, or high altitude [1]. * **Bone Marrow Examination:** In cases where PV is suspected (Low EPO + JAK2 mutation), a bone marrow biopsy is a **WHO major criterion**. It reveals "panmyelosis" (increased cellularity of erythroid, myeloid, and megakaryocytic lines). ### NEET-PG High-Yield Pearls * **WHO Criteria for PV:** Requires 3 Major (High Hb/Hct, BM Panmyelosis, JAK2 mutation) OR 2 Major + 1 Minor (Low Serum EPO). * **JAK2 V617F Mutation:** Present in >95% of PV cases [1]. * **Spurious Polycythemia (Gaisbock Syndrome):** Seen in stressed, hypertensive, obese males due to decreased plasma volume rather than increased red cell mass [1]. * **Rule of Thumb:** If EPO is high, look at the lungs (ABG) or kidneys (Ultrasound for Renal Cell Carcinoma).

Q: Calculate the total iron deficit for a 50 kg person with a hemoglobin level of 5 g/dL, including an additional 1000 mg for iron stores.

2150 mg. ### Explanation The calculation of iron deficiency is a high-yield topic for NEET-PG, typically determined using the **Ganzoni Formula**. This formula calculates the total iron deficit required to restore hemoglobin to a target level and replenish iron stores. **The Ganzoni Formula:** $\text{Total Iron Deficit (mg)} = \text{Body weight (kg)} \times (\text{Target Hb} - \text{Actual Hb}) \times 2.4 + \text{Iron stores (mg)}$ *Note: Target Hb is usually taken as 15 g/dL for adults.* **Step-by-Step Calculation:** 1. **Weight:** 50 kg 2. **Hb Deficit:** $(15 - 5) = 10 \text{ g/dL}$ 3. **Iron for Hb restoration:** $50 \times 10 \times 2.4 = 1200 \text{ mg}$ 4. **Iron for Stores:** Given as $1000 \text{ mg}$ 5. **Total Deficit:** $1200 + 1000 = \mathbf{2200 \text{ mg}}$ While the mathematical result is 2200 mg, **Option A (2150 mg)** is the closest clinical approximation provided. In some variations of the formula, a target Hb of 14.8 g/dL is used, which yields exactly 2176 mg, making 2150 mg the most appropriate choice. **Analysis of Incorrect Options:** * **Option B (1650 mg):** This value is too low; it likely underestimates the Hb deficit or uses an insufficient constant. * **Option C (1150 mg):** This represents only the iron needed for Hb restoration without adding the 1000 mg for stores. * **Option D (1575 mg):** This is a mathematical error often resulting from using an incorrect constant (e.g., 0.66 instead of 2.4). **Clinical Pearls for NEET-PG:** * **The Constant 2.4:** Derived from the blood volume (approx. 7% of body weight) and the iron content of hemoglobin (0.34%). * **Parenteral Iron:** Indicated in cases of oral iron intolerance, malabsorption (e.g., Celiac disease), or when rapid replenishment is needed (e.g., 3rd-trimester pregnancy) [1]. * **Iron Stores:** Always assume 500–1000 mg for adults unless specified otherwise [2]. For children, use 15 mg/kg.

Q: A patient has just been admitted to the hospital for observation. Based on the patient's laboratory results, what is the patient's primary problem? Hematocrit 45%, Hemoglobin 16 g/dL, Platelets 50 x 10^9/L.

Recurrent nosebleeds. **Explanation:** The laboratory results provided show a **normal Hematocrit (45%)** and **normal Hemoglobin (16 g/dL)**, but a significantly **low Platelet count (50 x 10⁹/L)**. This condition is known as **thrombocytopenia** [1]. 1. **Why "Recurrent nosebleeds" is correct:** Platelets are essential for primary hemostasis. When the platelet count drops below the normal range (150–450 x 10⁹/L), the patient becomes prone to mucosal bleeding [2]. Epistaxis (nosebleeds), petechiae, and gum bleeding are classic clinical manifestations of thrombocytopenia [2],[3]. A count of 50 x 10⁹/L is low enough to increase the risk of bleeding from minor trauma or spontaneously [1]. 2. **Why the other options are incorrect:** * **Hemochromatosis:** This is a disorder of iron overload. While it may lead to high hemoglobin in some contexts or cirrhosis in late stages, it is not primarily defined by isolated thrombocytopenia. * **Deep Vein Thrombosis (DVT) & Hepatic Vein Thrombosis (Budd-Chiari):** These are thrombotic (clotting) disorders. While conditions like Heparin-Induced Thrombocytopenia (HIT) or PNH can involve both clots and low platelets, isolated thrombocytopenia in a stable patient is statistically and clinically more likely to present with bleeding (like epistaxis) rather than a major venous thrombosis unless other risk factors are present. **High-Yield Clinical Pearls for NEET-PG:** * **Normal Platelet Range:** 1.5 to 4.5 lakh/mm³ (150–450 x 10⁹/L). * **Bleeding Risk:** Spontaneous bleeding usually does not occur until platelets are **<20 x 10⁹/L** [1]. Surgical bleeding risk increases when platelets are **<50 x 10⁹/L**. * **Primary vs. Secondary Hemostasis:** Platelet defects (quantitative or qualitative) lead to **mucocutaneous bleeding** (petechiae, purpura, epistaxis), whereas clotting factor deficiencies (e.g., Hemophilia) lead to **deep tissue bleeding** (hemarthrosis, hematomas) [2].

Question 1

Which of the following is NOT true regarding Waldenström's macroglobulinemia?

Accepted Answer

Hypercalcemia is present.

Answer

Lymphadenopathy is usually present.

Answer

Blood viscosity is increased.

Answer

IgM immunoglobulin is increased.

Question 2

A 23-year-old female presents with a 2-year history of anemia and jaundice. A peripheral smear shows spherocytes. What is the most appropriate investigation to perform?

Accepted Answer

Coombs test

Answer

Reticulocyte count

Answer

Osmotic fragility test

Answer

Bone marrow aspiration

Question 3

During the evaluation of a case of polycythemia, which of the following investigations is LEAST likely to be required to establish the cause?

Accepted Answer

Serum iron profile

Answer

Erythropoietin level

Answer

Arterial blood gas analysis

Answer

Bone marrow examination

Question 4

A patient with thalassemia major on repeated packed RBC transfusions and iron chelation therapy presents with a history of arrhythmias. During the current transfusion, she develops backache and appears anxious. What is the most appropriate next step in management?

Accepted Answer

Stop the transfusion and perform a clerical check of the blood group

Answer

Observe for changes in urine color

Answer

Continue the transfusion and perform an ECG

Answer

Stop the transfusion and wait for the patient to stabilize before resuming

Question 5

What is the first biochemical change noted after iron therapy is initiated?

Accepted Answer

Decreased transferrin saturation

Answer

Reticulocytosis

Answer

Increase in serum ferritin levels

Answer

Replenishment of iron stores

Question 6

Calculate the total iron deficit for a 50 kg person with a hemoglobin level of 5 g/dL, including an additional 1000 mg for iron stores.

Accepted Answer

2150 mg

Answer

1650 mg

Answer

1150 mg

Answer

1575 mg

Question 7

Which of the following is true about hemochromatosis?

Accepted Answer

It is associated with diabetes mellitus and slate grey discoloration of the skin.

Answer

It causes iron deficiency anemia.

Answer

Kayser Fleischer rings are seen in the eyes.

Answer

Autosomal dominant inheritance is the most common form.

Question 8

A patient has just been admitted to the hospital for observation. Based on the patient's laboratory results, what is the patient's primary problem? Hematocrit 45%, Hemoglobin 16 g/dL, Platelets 50 x 10^9/L.

Accepted Answer

Recurrent nosebleeds

Answer

Hemochromatosis

Answer

Deep vein thrombosis

Answer

Hepatic vein thrombosis

Question 9

Which one of the following laboratory tests differentiates leukemoid reaction from chronic myeloid leukemia?

Accepted Answer

Leukocyte alkaline phosphatase (LAP)

Answer

Leukocyte common antigen (LCA)

Answer

Myelo-peroxidase (MPO)

Answer

TRAP (tartrate resistant alkaline phosphatase)

Question 10

Which of the following is NOT true about aplastic anemia?

Accepted Answer

Splenomegaly

Answer

Reticulocytopenia

Answer

Thrombocytopenia

Answer

Neutropenia

Hematology — MCQs

Hematology — MCQs

On this page

Practice by Chapter

Want unlimited practice?